The screening and morbidity pattern of sickle cell anemia in chhattisgarh

Sumanta Panigrahi1, P K Patra2, P K Khodiar2

  • 1Department of Pediatrics, S.V.P.P.G.I.P. and S.C.B. Medical College and Hospital, Cuttack, Odisha India ; A/6, Sishubhaban Campus. Near High Court, Chandini Chowk, Cuttack, Odisha India.

Insights

This study screened 15,701 individuals for sickle cell anemia in Chhattisgarh, India. The prevalence of sickle cell trait (HbAS) was 10.6%, and sickle cell disease (HbSS) was 0.66%, with variations observed across age groups.

Area of Science:

  • Medical Science
  • Hematology
  • Genetics

Background:

  • Sickle cell anemia is a significant public health concern, particularly in certain regions of India.
  • Understanding the prevalence and clinical profiles of sickle cell disorders is crucial for targeted interventions.

Purpose of the Study:

  • To determine the prevalence of sickle cell anemia in three districts of Chhattisgarh, India.
  • To describe the clinical and hematological profiles of patients with sickle cell disease.

Main Methods:

  • A cross-sectional study involving screening of 15,701 individuals using solubility tests and Hb electrophoresis.
  • High-Performance Liquid Chromatography (HPLC) was used for further characterization of HbSS and inconclusive cases.
  • Clinical and hematological parameters were compared between vaso-occlusive crises and steady states.

Main Results:

  • The prevalence of sickle cell trait (HbAS) was 10.6% (1,672 individuals) and sickle cell disease (HbSS) was 0.66% (97 individuals).
  • Specific genotypes identified included Hb-S and beta-thalassemia minor (SB+), Hb-S and Hb-E (S/HBE), and Hb-S and Hb-D Punjab (S/HBD).
  • Homozygous patients exhibited decreased Hb, HCT, MCH, and RBC levels during vaso-occlusive crises compared to steady states (p < 0.001).

Conclusions:

  • Sickle cell anemia and trait are prevalent in the studied districts of Chhattisgarh.
  • Clinical manifestations, such as vaso-occlusive crises, are associated with significant hematological changes.
  • Fetal hemoglobin (HbF) levels above 15-20% may correlate with fewer crises, though high HbF can also indicate severe disease.